These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38608067)

  • 1. Effects of low fat diet on inflammatory parameters in individuals with obesity/overweight and non-alcoholic fatty liver disease: A cross-sectional study.
    Erdem NB; Kahramanoğlu Aksoy E; Dikmen D; Uçar Baş K; Ağaçdiken A; İlhan Esgin M; Göktaş Z
    Medicine (Baltimore); 2024 Apr; 103(15):e37716. PubMed ID: 38608067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-alcoholic fatty liver disease: The importance of physical activity and nutrition education-A randomized controlled study.
    Us Altay D; Kaya Y; Mataraci Değirmenci D; Kocyiğit E; Üner A; Noyan T
    J Gastroenterol Hepatol; 2024 Sep; ():. PubMed ID: 39343724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease.
    Biolato M; Manca F; Marrone G; Cefalo C; Racco S; Miggiano GA; Valenza V; Gasbarrini A; Miele L; Grieco A
    World J Gastroenterol; 2019 Jan; 25(4):509-520. PubMed ID: 30700946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial.
    Daneshi-Maskooni M; Keshavarz SA; Mansouri S; Qorbani M; Alavian SM; Badri-Fariman M; Jazayeri-Tehrani SA; Sotoudeh G
    Trials; 2017 Jun; 18(1):260. PubMed ID: 28592311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body mass index and the visceral adipose tissue expression of IL-6 and TNF-alpha are associated with the morphological severity of non-alcoholic fatty liver disease in individuals with class III obesity.
    Jorge ASB; Andrade JMO; Paraíso AF; Jorge GCB; Silveira CM; de Souza LR; Santos EP; Guimaraes ALS; Santos SHS; De-Paula AMB
    Obes Res Clin Pract; 2018; 12(Suppl 2):1-8. PubMed ID: 27083404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of a low fructose and low glycemic index/load (FRAGILE) dietary intervention on indices of liver function, cardiometabolic risk factors, and body composition in children and adolescents with nonalcoholic fatty liver disease (NAFLD).
    Mager DR; Iñiguez IR; Gilmour S; Yap J
    JPEN J Parenter Enteral Nutr; 2015 Jan; 39(1):73-84. PubMed ID: 23976771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, clinical & biochemical correlates of non-alcoholic fatty liver disease in overweight adolescents.
    Jain V; Jana M; Upadhyay B; Ahmad N; Jain O; Upadhyay AD; Ramakrishnan L; Vikram NK
    Indian J Med Res; 2018 Sep; 148(3):291-301. PubMed ID: 30425219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calorie-Restricted Mediterranean and Low-Fat Diets Affect Fatty Acid Status in Individuals with Nonalcoholic Fatty Liver Disease.
    Ristic-Medic D; Kovacic M; Takic M; Arsic A; Petrovic S; Paunovic M; Jovicic M; Vucic V
    Nutrients; 2020 Dec; 13(1):. PubMed ID: 33374554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-Alcoholic Fatty Liver Disease in Overweight Children: Role of Fructose Intake and Dietary Pattern.
    Nier A; Brandt A; Conzelmann IB; Özel Y; Bergheim I
    Nutrients; 2018 Sep; 10(9):. PubMed ID: 30235828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Association between regional fat mass and risk of nonalcoholic fatty liver disease in overweight/obese adults].
    Zeng Y; Yuan S; Xie M; Xiao T; Huang Z; Zhou J; He Q; Yang Y; Ma J
    Wei Sheng Yan Jiu; 2022 Sep; 51(5):753-760. PubMed ID: 36222034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between Mediterranean Diet and Fatty Liver in Women with Overweight and Obesity.
    Leone A; Bertoli S; Bedogni G; Vignati L; Pellizzari M; Battezzati A
    Nutrients; 2022 Sep; 14(18):. PubMed ID: 36145146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Metabolic and Hepatic Impact of Two Personalized Dietary Strategies in Subjects with Obesity and Nonalcoholic Fatty Liver Disease: The Fatty Liver in Obesity (FLiO) Randomized Controlled Trial.
    Marin-Alejandre BA; Abete I; Cantero I; Monreal JI; Elorz M; Herrero JI; Benito-Boillos A; Quiroga J; Martinez-Echeverria A; Uriz-Otano JI; Huarte-Muniesa MP; Tur JA; Martinez JA; Zulet MA
    Nutrients; 2019 Oct; 11(10):. PubMed ID: 31652512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary Inflammatory Index and liver status in subjects with different adiposity levels within the PREDIMED trial.
    Cantero I; Abete I; Babio N; Arós F; Corella D; Estruch R; Fitó M; Hebert JR; Martínez-González MÁ; Pintó X; Portillo MP; Ruiz-Canela M; Shivappa N; Wärnberg J; Gómez-Gracia E; Tur JA; Salas-Salvadó J; Zulet MA; Martínez JA
    Clin Nutr; 2018 Oct; 37(5):1736-1743. PubMed ID: 28734553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial.
    Friedrich D; Marschall HU; Lammert F
    BMC Gastroenterol; 2018 Jun; 18(1):76. PubMed ID: 29866129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver Fat Scores Moderately Reflect Interventional Changes in Liver Fat Content by a Low-Fat Diet but Not by a Low-Carb Diet.
    Kabisch S; Bäther S; Dambeck U; Kemper M; Gerbracht C; Honsek C; Sachno A; Pfeiffer AFH
    Nutrients; 2018 Jan; 10(2):. PubMed ID: 29385034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lipid metabolism in non-alcoholic fatty liver disease in patients with different body weights in mid-mountain conditions].
    Toktogulova NA; Sultanalieva RB; Tuhvatshin RR; Kaliev TK
    Ter Arkh; 2023 Jan; 94(12):1361-1366. PubMed ID: 37167179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
    Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
    Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of a carbohydrate restricted diet to treat non-alcoholic fatty liver disease in adolescents with obesity: Trial design and methodology.
    Dowla S; Pendergrass M; Bolding M; Gower B; Fontaine K; Ashraf A; Soleymani T; Morrison S; Goss A
    Contemp Clin Trials; 2018 May; 68():95-101. PubMed ID: 29601997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD).
    Cuthbertson DJ; Koskinen J; Brown E; Magnussen CG; Hutri-Kähönen N; Sabin M; Tossavainen P; Jokinen E; Laitinen T; Viikari J; Raitakari OT; Juonala M
    Ann Med; 2021 Dec; 53(1):1256-1264. PubMed ID: 34309471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prediction model of liver fat fraction and presence of non-alcoholic fatty liver disease (NAFLD) among patients with overweight or obesity.
    Chen J; Yue J; Fu J; He S; Liu Q; Yang M; Zhang W; Xu H; Lu Q; Ma J
    Endocr J; 2023 Oct; 70(10):977-985. PubMed ID: 37599066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.